Le Lézard
Classified in: Health
Subject: STP

Tufts Health Plan forms MassHealth Accountable Care Organization partnerships with four provider organizations


WATERTOWN, Mass., Aug. 18, 2017 /PRNewswire-USNewswire/ -- The Massachusetts Executive Office of Health and Human Services (EOHHS) recently announced that Tufts Health Plan has signed contracts to form Medicaid (MassHealth) Accountable Care Organization (ACO) partnerships with four provider organizations:  Atrius Health, Beth Israel Deaconess Care Organization, Cambridge Health Alliance, and Boston Children's Hospital Accountable Care Organization.

Tufts Health Plan (www.tuftshealthplan.com)

The new ACOs feature a value-based payment structure for providers who had largely been paid fee for service for MassHealth members in the past.  For members, this means the opportunity to receive medical, behavioral, dental and long-term support services in an integrated model of care.  This will improve quality of care, the member experience, and potentially help stabilize Medicaid costs in Massachusetts.

"We support the Commonwealth's goal of providing integrated health care to MassHealth members that is more efficient and improves their overall health," said Tom Croswell, president and CEO of Tufts Health Plan.  "We have partnered with four highly-regarded provider groups, all of whom share our vision of what collaboration and highly coordinated care can look like."

Continued Croswell:  "Tufts Health Plan has an excellent reputation for our collaborative approaches with providers.  We've been working with value-based contracts for more than 20+ years, starting in our Medicare Advantage plans.  We know first-hand that working closely with providers on coordinating care results in healthier members.  We're excited to broaden our success and bring this approach to our Medicaid members."

MassHealth ACO transformation is a major component in the state's five-year innovative 1115 Medicaid waiver from the federal government, which allows Massachusetts to restructure the current health care delivery system for 1.9 million MassHealth members.  

Tufts Health Plan's ACO partners are:

About Tufts Health Plan
Tufts Health Plan is nationally recognized for its commitment to providing innovative, high-quality health care coverage.  Staying true to our mission of improving the health and wellness of the diverse communities we serve, we touch the lives of more than 1.1 million members in Massachusetts, Rhode Island and New Hampshire through employer-sponsored plans; Medicare; Medicaid and Marketplace plans, offering health insurance coverage across the life span regardless of age or circumstance.

We continually rank among the top health plans in the country based on quality and member satisfaction:

To learn more about how we're redefining what a health plan can do, visit tuftshealthplan.com/ourstories. Connect with us on Facebook, Twitter, YouTube and LinkedIn.













[i] The National Committee for Quality Assurance Private Health Insurance Plan Rankings and Medicaid Health Insurance Rankings 2016-2017.


[ii] Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next. For more information on plan ratings, go to www.medicare.gov. Tufts Medicare Preferred HMO plans received 5 out of 5 stars for contract year 2016 and 2017.

Contact: Kathleen Makela
[email protected] 
857-304-8293

SOURCE Tufts Health Plan


These press releases may also interest you

at 01:18
. Hansa Biopharma, "Hansa" (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American...

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...

at 00:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy...



News published on and distributed by: